Concepedia

John R. Fulghum

JR

11

Publications

982

Citations

10

H-Index

1993

Active since

Affiliations

Vertex Pharmaceuticals (United States)(Current)

John R. Fulghum is an author at Vertex Pharmaceuticals (United States) specializing in medicine, molecular biology, and biochemistry.

Top concepts

Publications per year

1993–2014

11

Publications

11

In Vitro Resistance Studies of Hepatitis C Virus Serine Protease Inhibitors, VX-950 and BILN 2061

Chao Lin, Kai Lin, Yu-Ping Luong et al. · Journal of Biological Chemistry · 2004 · 289 citations · Full text

In Vitro Studies of Cross-resistance Mutations against Two Hepatitis C Virus Serine Protease Inhibitors, VX-950 and BILN 2061

Chao Lin, Cynthia A. Gates, B. Govinda Rao et al. · Journal of Biological Chemistry · 2005 · 216 citations · Full text

, , +14

Structure of Mitogen-activated Protein Kinase-activated Protein (MAPKAP) Kinase 2 Suggests a Bifunctional Switch That Couples Kinase Activation with Nuclear Export

Wuyi Meng, Lora Swenson, Matthew J. Fitzgibbon et al. · Journal of Biological Chemistry · 2002 · 131 citations · Full text

, , +20

High-throughput screening for soluble recombinant expressed kinases in Escherichia coli and insect cells

Stephen P. Chambers, Douglas A. Austen, John R. Fulghum et al. · Protein Expression and Purification · 2004 · 74 citations

, , +11

Biochemical Analysis of the Modular Enzyme Inosine 5′-Monophosphate Dehydrogenase

Elmar Nimmesgern, James Black, Olga Futer et al. · Protein Expression and Purification · 1999 · 58 citations

, ,

Rows per page

1–5 of 11